Australia markets closed

Pfizer Inc. (PFE)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
29.18-0.02 (-0.07%)
At close: 04:00PM EDT
29.28 +0.10 (+0.34%)
Pre-market: 05:34AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
55,165,000
58,496,000
100,330,000
81,288,000
41,651,000
Cost of revenue
23,511,000
24,954,000
34,344,000
30,821,000
8,484,000
Gross profit
31,654,000
33,542,000
65,986,000
50,467,000
33,167,000
Operating expenses
Research development
10,715,000
10,679,000
11,428,000
10,360,000
9,393,000
Selling general and administrative
15,069,000
14,771,000
13,677,000
12,703,000
11,597,000
Total operating expenses
30,845,000
30,183,000
28,714,000
26,763,000
24,338,000
Operating income or loss
809,000
3,359,000
37,272,000
23,704,000
8,829,000
Interest expense
2,951,000
2,209,000
1,238,000
1,291,000
1,449,000
Total other income/expenses net
-3,411,000
-1,716,000
-1,556,000
1,763,000
-415,000
Income before tax
-4,163,000
1,058,000
34,729,000
24,311,000
7,036,000
Income tax expense
-1,600,000
-1,115,000
3,328,000
1,852,000
370,000
Income from continuing operations
-2,564,000
2,172,000
31,401,000
22,459,000
6,666,000
Net income
-2,595,000
2,119,000
31,372,000
21,979,000
9,159,000
Net income available to common shareholders
-2,595,000
2,119,000
31,372,000
21,979,000
9,159,000
Basic EPS
1.85
0.38
5.59
3.92
1.73
Diluted EPS
1.83
0.37
5.47
3.85
1.71
Basic average shares
5,635,000
5,643,000
5,608,000
5,601,000
5,555,000
Diluted average shares
5,721,750
5,643,000
5,733,000
5,708,000
5,632,000